GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Hoja zilizoripotiwa na zaidi ya chombo kimoja

1. FDA requirement for NAION warnings on GLP-1 labelsvyombo 3 vya habari
2. NAION effects on visionvyombo 2 vya habari
3. Drugs covered by the FDA labeling requirementvyombo 2 vya habari
4. Evidence included in the FDA evaluationvyombo 2 vya habari